Introducing the new AltIndexLearn more
$11.2B 2.6%
Total revenue, Q1 '26 (USD).

Did Abbott Laboratories Beat Earnings?

Abbott Laboratories (ABT) reported Q1 '26 revenue of $11.2B, up 7.8% year-over-year, with reported EPS of $1.15. That matched the $1.15 analyst estimate.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Abbott Laboratories’s job postings, web traffic, and employee business outlook. See the full ABT stock analysis or the earnings calendar for upcoming reports.

ABT Earnings Surprise History (EPS vs. Estimate)

QuarterEstimated EPSReported EPSSurprise
Q1 '26 $1.15 $1.15 Met +0.0%
Q4 '25 $1.49 $1.50 Beat +0.7%
Q3 '25 $1.30 $1.30 Met +0.0%
Q2 '25 $1.26 $1.26 Met +0.0%
Q1 '25 $1.07 $1.09 Beat +1.9%
Q4 '24 $1.34 $1.34 Met +0.0%

Abbott Laboratories Quarterly Financial Trends (USD)

MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Revenue10.4B10.6B11B10.4B11.1B11.4B11.5B11.2B
Gross margin51.1%51.0%51.0%52.6%56.4%55.7%57.0%56.3%
Operating margin16.2%17.1%18.1%16.3%18.4%18.1%19.6%16.5%
Net income1.3B1.65B9.23B1.33B1.78B1.64B1.78B1.08B
Net margin12.5%15.5%84.1%12.8%16.0%14.5%15.5%9.6%
EPS$1.14$1.21$1.34$1.09$1.26$1.30$1.50$1.15

Abbott Laboratories Earnings Trend Analysis

Over the eight quarters from Q2 '24 to Q1 '26, Abbott Laboratories’s quarterly revenue moved from $10.4B to $11.2B. Net margin compressed from 12.5% to 9.6%, against a 56.3% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Abbott Laboratories has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.

When Is Abbott Laboratories’s Next Earnings Date?

Abbott Laboratories reports earnings on a quarterly schedule. Its most recent report covered Q1 '26. For the confirmed upcoming date — and every other company reporting soon — see the ABT earnings calendar.

Frequently Asked Questions: Abbott Laboratories Earnings

Abbott Laboratories's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Abbott Laboratories reported Q1 '26 EPS of $1.15 on revenue of $11.2B (+7.8% YoY). Abbott Laboratories reported EPS of $1.15.

Abbott Laboratories reported Q1 '26 revenue of $11.2B, up 7.8% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ABT AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.